Raymond James Financial Inc Astrazeneca PLC Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Raymond James Financial Inc holds 2,411,756 shares of AZN stock, worth $175 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,411,756Holding current value
$175 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,339Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.55 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.04 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.7 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.66 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...